Detalhe da pesquisa
1.
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
N Engl J Med;
377(9): 809-818, 2017 08 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28691557
2.
PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.
Blood;
124(3): 420-5, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24916506
3.
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.
Clin Cancer Res;
27(19): 5195-5212, 2021 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34321279
4.
Rituximab dosing in hematological malignancies: an old question, revisited.
Cancer Chemother Pharmacol;
84(3): 661-666, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30899984
5.
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.
Adv Ther;
34(10): 2232-2273, 2017 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28983798
6.
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.
J Clin Oncol;
35(5): 552-560, 2017 Feb 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28029309
7.
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.
Clin Cancer Res;
23(15): 3980-3993, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28428191
8.
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer.
J Transl Med;
3(1): 9, 2005 Feb 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15723705
9.
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.
J Transl Med;
3(1): 10, 2005 Mar 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15740633
10.
An interview with Nancy Valente, the Global Head of Hematology Development at Roche.
Expert Rev Hematol;
13(9): 929-932, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32684001
11.
Population pharmacokinetics of rituximab in patients with chronic lymphocytic leukemia.
J Clin Pharmacol;
52(12): 1918-26, 2012 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22235140
12.
Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.
J Clin Oncol;
28(10): 1756-65, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20194844
13.
Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma.
Leuk Lymphoma;
49(2): 227-36, 2008 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18231908